» Articles » PMID: 16595654

Phospholipase D Couples Survival and Migration Signals in Stress Response of Human Cancer Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Apr 6
PMID 16595654
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

MDA-MB-231 human breast cancer cells belong to a highly invasive metastatic cell line that depends on phospholipase D (PLD) activity for survival when deprived of serum growth factors. In response to the stress of serum withdrawal, there is a rapid and dramatic increase in PLD activity. Concomitant with increased PLD activity, there was an increase in the ability of MDA-MB-231 cells to both migrate and invade Matrigel. The ability of MDA-MB-231 cells to both migrate and invade Matrigel was dependent on both PLD and mTOR, a downstream target of PLD signals. Serum withdrawal also led to a PLD-dependent increase in the expression of the stress factor, hypoxia-inducible factor-1alpha. These data reveal that PLD survival signals not only prevent apoptosis but also stimulate cell migration and invasion, linking the ability to suppress apoptosis with the ability to metastasize.

Citing Articles

Phospholipase D2 downregulates interleukin-1β secretion from tumor-associated macrophages to suppress bladder cancer progression.

Hamada K, Nagumo Y, Kandori S, Isoda B, Suzuki S, Sano K Cancer Sci. 2024; 116(2):381-392.

PMID: 39528232 PMC: 11786306. DOI: 10.1111/cas.16393.


Decreased Expression of PLD2 Promotes EMT in Colorectal Cancer Invasion and Metastasis.

Liu X, Shen L, Wang H J Cancer. 2024; 15(10):2981-2993.

PMID: 38706911 PMC: 11064252. DOI: 10.7150/jca.89970.


Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.

Munoz-Galvan S, Verdugo-Sivianes E, Santos-Pereira J, Estevez-Garcia P, Carnero A J Exp Clin Cancer Res. 2024; 43(1):57.

PMID: 38403587 PMC: 10895852. DOI: 10.1186/s13046-024-02988-y.


Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients.

Lo Presti C, Yamaryo-Botte Y, Mondet J, Berthier S, Nutiu D, Botte C Int J Mol Sci. 2023; 24(6).

PMID: 36983080 PMC: 10054724. DOI: 10.3390/ijms24065988.


mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells.

Panuzzo C, Pironi L, Maglione A, Rocco S, Stanga S, Riganti C Int J Mol Sci. 2023; 24(2).

PMID: 36674750 PMC: 9865638. DOI: 10.3390/ijms24021234.